Sign in
IZTC Stock Price, Chart, Stats & News
Invizyne Technologies Inc. Common Stock
Save
Invizyne Technologies Inc. Common Stock (IZTC) does not currently pay a dividend.
157.23M
Market cap
–
Current P/E
–
Forward P/E
IZTC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -84.26% |
ROE | -81.52% |
D/E | 0.19x |
Interest coverage ratio | – |
IZTC valuation
P/E | – |
P/S | – |
P/B | 25.75x |
P/CF | -30.56x |
P/FCF | -34.01x |
P/OCF | -30.56x |
PEG | 0.39x |
EV multiple | -84.80x |
About
Invizyne Technologies Inc. is an American synthetic biochemical company that has developed SimplePath, an innovative platform. This technology is designed to synthesize a diverse range of chemicals, including vital substances like pharmaceuticals, fuels, and advanced materials, as well as food additives and entirely novel compounds. At its core, SimplePath is composed of specialized modules, each integrating one or more enzymes that collaboratively execute defined biocatalytic conversions.
Similar securities
Based on sector and market capitalization
Report issue